学生论文
论文查询结果 |
返回搜索 |
|
论文编号: | 14234 | |
作者编号: | 2320200283 | |
上传时间: | 2023/12/9 10:37:28 | |
中文题目: | M公司高值医疗器械业务在华竞争战略研究 | |
英文题目: | Research on the Competitive Strategy of M Company''s High Value Medical Consumables Business in China | |
指导老师: | 任兵 | |
中文关键字: | 医疗器械,外资公司,竞争战略 | |
英文关键字: | medical devices, foreign companies, competitive strategies | |
中文摘要: | 本论文以医疗器械行业巨头M公司为研究对象,基于对医疗行业相关的政治、经济和社会等进行研究,并结合M公司在中国医疗市场发展情况分析,得出如下结论:对于外国医疗器械公司来说,既存在重大发展机遇如市场需求增加、政策支持力度加大等,同时也存在市场准入更严格、医疗器械要求集中采购等带来的诸多挑战。如以领先的医疗器械公司M公司为例,将研究其目前开展市场营销情况,分析该公司的人力资源管理和技术创新能力,指出M公司在当今新医疗环境下的优势和劣势,在这基础上结合中国市场政策及M公司自身发展目标研究其在华的竞争战略,以实现在中国的盈利性增长。M公司在中国的竞争战略应是低成本的战略,主要集中在四个方面:制造、营销、研发和人力资源。通过M公司制定战略的可行性分析,具体战略举措的实施与保障等内容,可以评估M公司在中国的战略是否能够为公司在中国医疗领域提供竞争优势和可持续增长。本研究以期能为M公司在中国运营发展提供参考作用,同时还能为其他医疗器械公司在中国医疗市场新环境下制定战略提供借鉴。 | |
英文摘要: | This thesis takes M Company, a giant in the medical device industry, as the research object. Based on the research on the politics, economy and society related to the medical industry, and combined with the analysis of M Company's development in China's medical market, the following conclusions are drawn: For foreign medical device companies, there are major development opportunities such as increased market demand, increased policy support, etc., but also there are many challenges brought by stricter market access and centralized procurement of medical devices. Taking M Company, a leading medical device company, as an example, this thesis will study its current marketing situation, analyze the company's human resource management and technological innovation capabilities, point out the advantages and disadvantages of M company in the current new medical environment, and on this basis, combine the Chinese market policy and M company's own development goals to study its competitive strategy in China, so as to achieve profitable growth in China. M Company's competitive strategy in China should be a low-cost strategy, mainly focusing on four aspects: manufacturing, marketing, research and development and human resources. Through the feasibility analysis of M Company's strategy formulation and the implementation and guarantee of specific strategic measures, we can evaluate whether M Company's strategy in China can provide competitive advantages and sustainable growth for M company in China's medical field. This study is expected to provide reference for the operation and development of M company in China, and also provide reference for other medical device companies to formulate strategies under the new environment of China's medical market. | |
查看全文: | 预览 下载(下载需要进行登录) |